<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Much has been accomplished in the cure of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> with chemotherapy, but much remains to be done </plain></SENT>
<SENT sid="1" pm="."><plain>The primary care physician's responsibility is to know which <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are curable and in which a significant portion of patients may benefit from chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in a relatively resistant organ site represent the greatest challenge to the "art" of medicine </plain></SENT>
<SENT sid="3" pm="."><plain>Even if more than half of patients with a given <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> are cured by chemotherapy, the remainder deserve the right to participate in research protocols, an undertaking that might further improve these otherwise substantial gains </plain></SENT>
<SENT sid="4" pm="."><plain>As research studies show improved cure rates with <z:chebi fb="0" ids="35610">antineoplastic agents</z:chebi>, the need to reduce both short- and long-term side effects will remain a challenge </plain></SENT>
</text></document>